Sentinel lymph node (SLN) status alone is not sufficient as node negative patients still experience relapse and melanoma-related death. Validates Merlin CP-GEP’s prognostic power: Identifying tumors at high-risk for relapse that would otherwise be missed by traditional clinical and…